Chongqing Zhifei Biological Products Co., Ltd. (SHE:300122)
China
· Delayed Price · Currency is CNY 16.16
-0.01 (-0.06%)
Mar 10, 2026, 11:15 AM CST
SHE:300122 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 38,708 | 62,957 | 146,664 | 140,528 | 199,360 | 236,656 | Upgrade
|
| Market Cap Growth | -37.35% | -57.07% | 4.37% | -29.51% | -15.76% | 197.84% | Upgrade
|
| Enterprise Value | 50,583 | 68,773 | 148,099 | 139,912 | 195,638 | 238,780 | Upgrade
|
| Last Close Price | 16.17 | 26.30 | 58.88 | 56.01 | 79.02 | 93.54 | Upgrade
|
| PE Ratio | - | 31.19 | 18.17 | 18.64 | 19.53 | 71.69 | Upgrade
|
| Forward PE | 11.24 | 14.60 | 15.39 | 19.63 | 21.81 | 52.81 | Upgrade
|
| PS Ratio | 3.55 | 2.42 | 2.77 | 3.67 | 6.50 | 15.58 | Upgrade
|
| PB Ratio | 1.31 | 2.04 | 4.66 | 5.80 | 11.29 | 28.69 | Upgrade
|
| P/TBV Ratio | 1.35 | 2.06 | 4.71 | 5.89 | 11.53 | 29.74 | Upgrade
|
| P/FCF Ratio | 39.03 | - | 18.65 | 262.21 | 30.32 | 88.65 | Upgrade
|
| P/OCF Ratio | 25.45 | - | 16.30 | 70.65 | 23.43 | 67.68 | Upgrade
|
| PEG Ratio | - | - | 0.86 | 19.63 | 0.66 | 0.77 | Upgrade
|
| EV/Sales Ratio | 4.64 | 2.64 | 2.80 | 3.66 | 6.38 | 15.72 | Upgrade
|
| EV/EBITDA Ratio | - | 25.38 | 15.56 | 15.54 | 15.91 | 57.79 | Upgrade
|
| EV/EBIT Ratio | - | 29.42 | 16.09 | 16.09 | 16.41 | 59.53 | Upgrade
|
| EV/FCF Ratio | 51.01 | - | 18.84 | 261.06 | 29.75 | 89.44 | Upgrade
|
| Debt / Equity Ratio | 0.48 | 0.40 | 0.10 | 0.08 | 0.05 | 0.35 | Upgrade
|
| Debt / EBITDA Ratio | - | 4.54 | 0.32 | 0.23 | 0.07 | 0.70 | Upgrade
|
| Debt / FCF Ratio | 14.22 | - | 0.39 | 3.79 | 0.12 | 1.08 | Upgrade
|
| Net Debt / Equity Ratio | 0.39 | 0.31 | -0.10 | -0.02 | -0.20 | 0.17 | Upgrade
|
| Net Debt / EBITDA Ratio | -12.30 | 3.56 | -0.35 | -0.06 | -0.28 | 0.35 | Upgrade
|
| Net Debt / FCF Ratio | 11.70 | -1.81 | -0.42 | -1.10 | -0.53 | 0.54 | Upgrade
|
| Asset Turnover | 0.22 | 0.52 | 1.20 | 1.13 | 1.35 | 1.16 | Upgrade
|
| Inventory Turnover | 0.40 | 1.22 | 4.59 | 3.31 | 2.92 | 3.16 | Upgrade
|
| Quick Ratio | 1.23 | 1.03 | 1.85 | 1.76 | 1.45 | 1.18 | Upgrade
|
| Current Ratio | 2.80 | 2.24 | 2.35 | 2.37 | 2.09 | 1.69 | Upgrade
|
| Return on Equity (ROE) | -4.24% | 6.48% | 28.95% | 35.99% | 78.81% | 47.17% | Upgrade
|
| Return on Assets (ROA) | -1.70% | 2.92% | 13.04% | 15.98% | 32.93% | 19.17% | Upgrade
|
| Return on Invested Capital (ROIC) | -3.27% | 6.10% | 30.68% | 39.78% | 85.55% | 41.23% | Upgrade
|
| Return on Capital Employed (ROCE) | -4.10% | 7.40% | 28.60% | 35.10% | 65.60% | 47.80% | Upgrade
|
| Earnings Yield | -3.38% | 3.21% | 5.50% | 5.37% | 5.12% | 1.40% | Upgrade
|
| FCF Yield | 2.56% | -8.49% | 5.36% | 0.38% | 3.30% | 1.13% | Upgrade
|
| Dividend Yield | 1.24% | 0.76% | 1.36% | 0.60% | 0.51% | 0.36% | Upgrade
|
| Payout Ratio | - | 125.23% | 11.02% | 13.46% | 8.44% | 28.13% | Upgrade
|
| Buyback Yield / Dilution | 0.00% | 0.20% | 0.00% | 0.00% | 0.00% | -0.00% | Upgrade
|
| Total Shareholder Return | 1.24% | 0.96% | 1.36% | 0.60% | 0.51% | 0.35% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.